Coverage
Filings
| Filing | Date |
|---|---|
| Holding(s) in Company | 31 Aug 2023 |
| Director/PDMR Shareholding | 25 Aug 2023 |
| Shingrix data demonstrate 100% efficacy in China | 23 Aug 2023 |
| Director/PDMR Shareholding | 23 Aug 2023 |
| Director/PDMR Shareholding | 22 Aug 2023 |
| Director/PDMR Shareholding | 10 Aug 2023 |
| Director/PDMR Shareholding | 9 Aug 2023 |
| Total Voting Rights | 1 Aug 2023 |
| Director/PDMR Shareholding |
GSK said Monday it has appointed Chief Commercial Officer Luke Miels as its next chief executive, succeeding Dame Emma Walmsley.
GSK PLC announced plans to invest $30 billion in the United States over the next five years to boost its research, development, and manufacturing capabilities.
GSK said on Monday that the U.S. Food and Drug Administration has accepted for review its application to expand the use of its respiratory syncytial virus vaccine, Arexvy, to at-risk adults aged 18 to 49.
| 31 Jul 2023 |
| FDA approves new use for Jemperli plus chemo | 31 Jul 2023 |
| Director/PDMR Shareholding | 28 Jul 2023 |
| 2nd Quarter Results | 26 Jul 2023 |